{"id":"https://openalex.org/W4285389727","doi":"https://doi.org/10.3389/fonc.2022.891886","title":"Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer","display_name":"Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer","alternate_titles":[],"publication_year":2022,"publication_date":"2022-07-14","ids":{"openalex":"https://openalex.org/W4285389727","doi":"https://doi.org/10.3389/fonc.2022.891886","pmid":"https://pubmed.ncbi.nlm.nih.gov/35912190","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9329530"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.891886","doi":"https://doi.org/10.3389/fonc.2022.891886","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.891886","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4285389727"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fonc.2022.891886","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002657236","display_name":"Pedro C. Lara","orcid":"https://orcid.org/0000-0003-1709-6232","observed_orcids":["https://orcid.org/0000-0003-1709-6232"]},"institutions":[{"id":"https://openalex.org/I4210090580","display_name":"Universidad Fernando Pessoa Canarias","ror":"https://ror.org/00bqe3914","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210090580"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Pedro C. Lara","raw_affiliation_strings":["Canarian Comprehensive Cancer Center, San Roque University Hospital, Fernando Pessoa Canarias University, Las Palmas, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Canarian Comprehensive Cancer Center, San Roque University Hospital, Fernando Pessoa Canarias University, Las Palmas, Spain","institution_ids":["https://openalex.org/I4210090580"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041424422","display_name":"J.I. Rodr\u00edguez-Melc\u00f3n","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098027","display_name":"Hospital Universitario de Gran Canaria Doctor Negr\u00edn","ror":"https://ror.org/00s4vhs88","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210098027"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Juan I. Rodr\u00edguez-Melc\u00f3n","raw_affiliation_strings":["Radiation Oncology. Dr. Negr\u00edn University Hospital, Las Palmas, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology. Dr. Negr\u00edn University Hospital, Las Palmas, Spain","institution_ids":["https://openalex.org/I4210098027"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029321506","display_name":"Amalia Palacios","orcid":"https://orcid.org/0000-0002-7575-227X","observed_orcids":["https://orcid.org/0000-0002-7575-227X"]},"institutions":[{"id":"https://openalex.org/I4210093628","display_name":"Instituto Maim\u00f3nides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba","ror":"https://ror.org/00j9b6f88","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210093628"]},{"id":"https://openalex.org/I4210123675","display_name":"Hospital Universitario Reina Sof\u00eda","ror":"https://ror.org/02vtd2q19","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210123675"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Amalia Palacios-Eito","raw_affiliation_strings":["Radiation Oncology, Reina Sof\u00eda University Hospital, Instituto Maim\u00f3nides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba, C\u00f3rdoba, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology, Reina Sof\u00eda University Hospital, Instituto Maim\u00f3nides de Investigaci\u00f3n Biom\u00e9dica de C\u00f3rdoba, C\u00f3rdoba, Spain","institution_ids":["https://openalex.org/I4210093628","https://openalex.org/I4210123675"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110132679","display_name":"Antonio Jos\u00e9 Lozano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150677","display_name":"Hospital Universitario Virgen de la Arrixaca","ror":"https://ror.org/058thx797","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210150677"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonio Lozano","raw_affiliation_strings":["Radiation Oncology, Virgen de la Arriexaca University Hospital, Murcia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology, Virgen de la Arriexaca University Hospital, Murcia, Spain","institution_ids":["https://openalex.org/I4210150677"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083400688","display_name":"Asuncion Hervas","orcid":"https://orcid.org/0000-0002-7439-1820","observed_orcids":["https://orcid.org/0000-0002-7439-1820"]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Asunci\u00f3n Herv\u00e1s-Mor\u00f3n","raw_affiliation_strings":["Radiation Oncology, Ramon y Cajal University Hospital, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology, Ramon y Cajal University Hospital, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080552396","display_name":"Elena Villafranca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena Villafranca","raw_affiliation_strings":["Radiation Oncology, Navarra University Hospital, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology, Navarra University Hospital, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085867926","display_name":"Alfonso Gomez Iturriaga","orcid":"https://orcid.org/0000-0002-1094-5839","observed_orcids":["https://orcid.org/0000-0002-1094-5839"]},"institutions":[{"id":"https://openalex.org/I4210089430","display_name":"BioCruces Health research Institute","ror":"https://ror.org/0061s4v88","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210089430"]},{"id":"https://openalex.org/I4210137412","display_name":"Hospital de Cruces","ror":"https://ror.org/03nzegx43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210125364","https://openalex.org/I4210137412"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alfonso G\u00f3mez-Iturriaga","raw_affiliation_strings":["Radiation Oncology, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain","institution_ids":["https://openalex.org/I4210089430","https://openalex.org/I4210137412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053439830","display_name":"Gemma Sancho","orcid":"https://orcid.org/0000-0003-2266-6172","observed_orcids":["https://orcid.org/0000-0003-2266-6172"]},"institutions":[{"id":"https://openalex.org/I2801795740","display_name":"Hospital de Sant Pau","ror":"https://ror.org/059n1d175","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2801795740"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Gemma Sancho","raw_affiliation_strings":["Radiation Oncology, San Creu I San Pau University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology, San Creu I San Pau University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I2801795740"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015037372","display_name":"Xavier Maldonado","orcid":"https://orcid.org/0000-0003-2045-4723","observed_orcids":["https://orcid.org/0000-0003-2045-4723"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Xavier Maldonado","raw_affiliation_strings":["Radiation Oncology, Vall d\u00b4Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology, Vall d\u00b4Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5002657236"],"corresponding_institution_ids":["https://openalex.org/I4210090580"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.0193,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.72113785,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"12","issue":null,"first_page":"891886","last_page":"891886"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.9218999743461609,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.9218999743461609,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.07029999792575836,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9179999828338623},{"id":"https://openalex.org/keywords/intermediate-risk-prostate-cancer","display_name":"intermediate-risk prostate cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/localized-prostate-cancer","display_name":"localized prostate cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.8870000243186951},{"id":"https://openalex.org/keywords/gynecomastia","display_name":"gynecomastia","score":0.9750000238418579},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6539999842643738},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.954508364200592},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9079052805900574},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8778826594352722},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.6238592267036438},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.6222566962242126},{"id":"https://openalex.org/C2777691561","wikidata":"https://www.wikidata.org/wiki/Q339221","display_name":"Gynecomastia","level":2,"score":0.5856205821037292},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5356964468955994},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4845963716506958},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4755896329879761},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4373752176761627},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42283836007118225},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.20691674947738647},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.09592887759208679}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fonc.2022.891886","doi":"https://doi.org/10.3389/fonc.2022.891886","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.891886","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:35912190","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35912190","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9329530","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9329530/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:www.repositoriosalud.es:10668/20683","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329530/pdf","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.891886/pdf","source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"},{"id":"pmh:oai:ddd.uab.cat:282306","doi":null,"is_oa":true,"landing_page_url":"https://ddd.uab.cat/record/282306","pdf_url":null,"source":{"id":"https://openalex.org/S4306400380","display_name":"Dip\u00f2sit Digital de Documents de la UAB (Universitat Aut\u00f2noma de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I123044942","host_organization_name":"Universitat Aut\u00f2noma de Barcelona","host_organization_lineage":["https://openalex.org/I123044942"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:c70f8a99ebe74f68bb2aca7108584a78","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c70f8a99ebe74f68bb2aca7108584a78","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.891886","doi":"https://doi.org/10.3389/fonc.2022.891886","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.891886","pdf_url":null,"source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4285389727.pdf","grobid_xml":"https://content.openalex.org/works/W4285389727.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W2000780929","https://openalex.org/W2003340521","https://openalex.org/W2005958584","https://openalex.org/W2020740347","https://openalex.org/W2049161486","https://openalex.org/W2051563205","https://openalex.org/W2061554699","https://openalex.org/W2075529011","https://openalex.org/W2116582477","https://openalex.org/W2119504728","https://openalex.org/W2119690256","https://openalex.org/W2122822449","https://openalex.org/W2129550487","https://openalex.org/W2139935864","https://openalex.org/W2140905531","https://openalex.org/W2148664597","https://openalex.org/W2160406420","https://openalex.org/W2166918329","https://openalex.org/W2252849995","https://openalex.org/W2337386322","https://openalex.org/W2339647035","https://openalex.org/W2465092116","https://openalex.org/W2585109238","https://openalex.org/W2586431548","https://openalex.org/W2600594844","https://openalex.org/W2601353955","https://openalex.org/W2603384438","https://openalex.org/W2753160869","https://openalex.org/W2768924090","https://openalex.org/W2810806599","https://openalex.org/W2931472946","https://openalex.org/W2947893479","https://openalex.org/W2951410441","https://openalex.org/W2963794755","https://openalex.org/W3024006673","https://openalex.org/W3110475042","https://openalex.org/W3131106968","https://openalex.org/W3185550549","https://openalex.org/W4205575843","https://openalex.org/W4247126447","https://openalex.org/W4249568719"],"related_works":["https://openalex.org/W3131106968","https://openalex.org/W2790634264","https://openalex.org/W2973191641","https://openalex.org/W4221026384","https://openalex.org/W2075529011","https://openalex.org/W7163727223","https://openalex.org/W4235257983","https://openalex.org/W2626118799","https://openalex.org/W7223470349","https://openalex.org/W4282968863"],"abstract_inverted_index":{"Background:":[0],"Intermediate-risk":[1],"prostate":[2,75,98,241],"cancer":[3],"(PCa)":[4],"is":[5,27,46,227,245],"usually":[6],"treated":[7],"by":[8],"a":[9,18,81],"combination":[10,254],"of":[11,21,37,52,55,63,87,90,120,127,156,167,186,195,252],"external":[12],"beam":[13],"radiation":[14],"therapy":[15,24],"(EBRT)":[16],"and":[17,39,136,170,206],"short":[19],"course":[20],"androgen":[22],"deprivation":[23],"(ADT).":[25],"ADT":[26],"associated":[28],"with":[29,67,94,231,239],"multiple":[30],"side":[31],"effects,":[32],"including":[33],"weight":[34],"gain,":[35],"loss":[36],"libido,":[38],"hot":[40],"flashes.":[41],"In":[42],"contrast,":[43],"anti-androgen":[44],"monotherapy":[45,65,92,226],"generally":[47],"better":[48],"tolerated":[49],"in":[50,130,144,160,181,213,233,255],"spite":[51],"higher":[53],"rates":[54],"gynecomastia.":[56,207],"Objective:":[57],"This":[58,78],"study":[59,86,146],"assessed":[60],"the":[61,117,145,165,187,193,249],"effectiveness":[62],"enzalutamide":[64,91,121,168,196],"combined":[66,93],"hypofractionated":[68],"EBRT":[69],"(Hypo-EBRT)":[70],"for":[71,96,237],"treating":[72],"intermediate":[73],"risk":[74],"cancer.":[76,99,242],"Method:":[77],"trial":[79],"was":[80,101,111,158],"multicenter,":[82],"open-label":[83],"phase":[84],"II":[85],"6":[88,190],"months":[89,191],"Hypo-EBRT":[95,100],"intermediate-risk":[97,240],"initiated":[102],"8-12":[103],"weeks":[104],"after":[105,192],"initiating":[106],"enzalutamide.":[107],"The":[108,198],"primary":[109],"endpoint":[110],"PSA":[112,154,173,182,235],"decline":[113,155],">80%":[114,157],"measured":[115],"at":[116,164],"25th":[118],"week":[119],"administration.":[122],"Secondary":[123],"end-points":[124],"included":[125,143],"assessment":[126],"toxicity,":[128],"changes":[129,212],"anthropomorphic":[131],"body":[132,216],"measurements,":[133],"sexual":[134],"hormones,":[135],"metabolic":[137],"changes.":[138],"Results:":[139],"Sixty-two":[140],"patients":[141,163,179,238],"were":[142,203,209],"from":[147],"January":[148],"2018":[149],"to":[150,247],"February":[151],"2020.":[152],"A":[153],"observed":[159],"all":[161],"evaluable":[162],"end":[166,194],"treatment":[169],"92%":[171],"achieved":[172],"values":[174],"under":[175],"0.1":[176],"ngr/ml.":[177],"All":[178],"remain":[180],"response":[183],"(<80%":[184],"reduction":[185],"initial":[188],"values)":[189],"treatment.":[197],"most":[199],"frequent":[200],"adverse":[201],"events":[202],"hypertension,":[204],"asthenia,":[205],"There":[208],"no":[210],"significant":[211],"bone":[214],"density,":[215],"mass":[217],"index":[218],"(BMI),":[219],"or":[220],"patient-reported":[221],"outcomes":[222],"(PROs).":[223],"Conclusion:":[224],"Enzalutamide":[225],"very":[228],"effective":[229],"along":[230],"hEBRT":[232],"reducing":[234],"levels":[236],"Longer":[243],"follow-up":[244],"needed":[246],"confirm":[248],"potential":[250],"use":[251],"this":[253],"future":[256],"randomized":[257],"trials.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4285389727","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2022-07-14T00:00:00"}
